BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Price predictions

  1. 560 Posts.
    lightbulb Created with Sketch. 118
    Getting a bit tired of the conversation in other threads.

    With a few milestones ahead in the form of potentially successful products such as:

    -Sofpironium Bromide (NDA in review, expecting FDA approval 3Q 2023)
    -Acne BTX1503 (Pending Phase 3 study)
    -Rosacea BTX1702 (Positive Phase 1b/2 results)
    -Dermatitis TX 1204A (Canine proof-of-concept study complete)
    -Antimicrobial BTX 1801, (Phase 2a study (successfully completed).Phase 2b study (pending).)

    ...I would like to kick around price predictions and your reasons for the prediction (just a gut feel is fine). I've been with this mob for several years now, slowly growing my parcel of shares, but I'm essentially a novice with calculating or even guessing price expectations.

    I'm hearing 50cents after SB in September. What do you think, hope, or expect?
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.